Literature DB >> 18349069

Reproductive history and hormonal birth control use are associated with coronary calcium progression in women with type 1 diabetes mellitus.

Janet K Snell-Bergeon1, Dana Dabelea, Lorraine G Ogden, John E Hokanson, Gregory L Kinney, James Ehrlich, Marian Rewers.   

Abstract

CONTEXT: Coronary artery disease is increased in women with type 1 diabetes (T1D), compared with nondiabetic (Non-DM) women. Women with T1D have more menstrual dysfunction and are less likely to use hormonal birth control (BC) than Non-DM women.
OBJECTIVE: The purpose of this study was to determine whether coronary artery calcium (CAC) is associated with menstrual dysfunction and BC use in women with T1D.
MATERIALS AND METHODS: This was a prospective cohort study, and participants were followed up for an average of 2.4 yr. PATIENTS: Patients included 612 women (293 T1D, 319 Non-DM) between the ages of 19 and 55 yr who had CAC measured twice by electron beam tomography.
RESULTS: Irregular menses and amenorrhea were more common in T1D than Non-DM women (22.1 vs. 14.9%, P < 0.05 and 16.6 vs. 7.0%, P < 0.001). T1D women reported less BC use than Non-DM women (79.8 vs. 89.9%, P < 0.001) and reached menarche at an older age (13.1 +/- 1.8 vs. 12.8 +/- 1.5 yr, P < 0.05). Use of BC was associated with less CAC progression in all women, but this association was stronger in T1D women (P value for interaction = 0.02). Irregular menses were associated with greater CAC progression only among T1D women.
CONCLUSIONS: A prior history of BC use is associated with reduced CAC progression among all women, with a stronger association in T1D than in Non-DM women. Women with T1D who report irregular menses have increased CAC progression, compared with those with regular menses.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18349069      PMCID: PMC2435635          DOI: 10.1210/jc.2007-2025

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  38 in total

1.  Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.

Authors: 
Journal:  Circulation       Date:  2002-12-17       Impact factor: 29.690

Review 2.  Reproductive hormones and cardiovascular disease mechanism of action and clinical implications.

Authors:  Janice D Wagner; Jay R Kaplan; Ronald T Burkman
Journal:  Obstet Gynecol Clin North Am       Date:  2002-09       Impact factor: 2.844

3.  Menopause in type 1 diabetic women: is it premature?

Authors:  J S Dorman; A R Steenkiste; T P Foley; E S Strotmeyer; J P Burke; L H Kuller; C K Kwoh
Journal:  Diabetes       Date:  2001-08       Impact factor: 9.461

4.  Oral contraceptive use and hormone replacement therapy are associated with microalbuminuria.

Authors:  T B Monster; W M Janssen; P E de Jong; L T de Jong-van den Berg
Journal:  Arch Intern Med       Date:  2001-09-10

5.  Menstrual cycle irregularity and risk for future cardiovascular disease.

Authors:  Caren G Solomon; Frank B Hu; Andrea Dunaif; Janet E Rich-Edwards; Meir J Stampfer; Walter C Willett; Frank E Speizer; Joann E Manson
Journal:  J Clin Endocrinol Metab       Date:  2002-05       Impact factor: 5.958

6.  Correlation between glycemic control and menstruation in diabetic adolescents.

Authors:  B Schroeder; S P Hertweck; J S Sanfilippo; M B Foster
Journal:  J Reprod Med       Date:  2000-01       Impact factor: 0.142

7.  Premenopausal social status and hormone exposure predict postmenopausal atherosclerosis in female monkeys.

Authors:  J R Kaplan; S B Manuck; M S Anthony; T B Clarkson
Journal:  Obstet Gynecol       Date:  2002-03       Impact factor: 7.661

8.  The effect of type 1 diabetes mellitus on the gender difference in coronary artery calcification.

Authors:  H M Colhoun; M B Rubens; S R Underwood; J H Fuller
Journal:  J Am Coll Cardiol       Date:  2000-12       Impact factor: 24.094

9.  Contraception in diabetic women: comparative metabolic study of Norplant, depot medroxyprogesterone acetate, low dose oral contraceptive pill and CuT380A.

Authors:  K M Diab; M M Zaki
Journal:  J Obstet Gynaecol Res       Date:  2000-02       Impact factor: 1.730

Review 10.  Long-term health consequences of PCOS.

Authors:  Robert A Wild
Journal:  Hum Reprod Update       Date:  2002 May-Jun       Impact factor: 15.610

View more
  14 in total

Review 1.  When are type 1 diabetic patients at risk for cardiovascular disease?

Authors:  Trevor J Orchard; Tina Costacou
Journal:  Curr Diab Rep       Date:  2010-02       Impact factor: 4.810

Review 2.  Diabetes and Menopause.

Authors:  Carrie A Karvonen-Gutierrez; Sung Kyun Park; Catherine Kim
Journal:  Curr Diab Rep       Date:  2016-04       Impact factor: 4.810

3.  Sex-specific differences in insulin resistance in type 1 diabetes: The CACTI cohort.

Authors:  Richard J Millstein; Laura L Pyle; Bryan C Bergman; Robert H Eckel; David M Maahs; Marian J Rewers; Irene E Schauer; Janet K Snell-Bergeon
Journal:  J Diabetes Complications       Date:  2018-01-10       Impact factor: 2.852

4.  Coronary artery calcium may stabilize following islet cell transplantation in patients with type 1 diabetes.

Authors:  Jessica M Madrigal; Rebecca S Monson; Betul Hatipoglu; José Oberholzer; George T Kondos; Krista A Varady; Kirstie K Danielson
Journal:  Clin Transplant       Date:  2017-08-19       Impact factor: 2.863

5.  Impairment of ovarian function and associated health-related abnormalities are attributable to low social status in premenopausal monkeys and not mitigated by a high-isoflavone soy diet.

Authors:  J R Kaplan; H Chen; S E Appt; C J Lees; A A Franke; S L Berga; M E Wilson; S B Manuck; T B Clarkson
Journal:  Hum Reprod       Date:  2010-10-17       Impact factor: 6.918

Review 6.  Contraceptive hormone use and cardiovascular disease.

Authors:  Chrisandra L Shufelt; C Noel Bairey Merz
Journal:  J Am Coll Cardiol       Date:  2009-01-20       Impact factor: 24.094

Review 7.  Is the risk and nature of CVD the same in type 1 and type 2 diabetes?

Authors:  Lindsey Duca; Rachel Sippl; Janet K Snell-Bergeon
Journal:  Curr Diab Rep       Date:  2013-06       Impact factor: 4.810

Review 8.  Menarche delay and menstrual irregularities persist in adolescents with type 1 diabetes.

Authors:  Bahareh M Schweiger; Janet K Snell-Bergeon; Rossana Roman; Kim McFann; Georgeanna J Klingensmith
Journal:  Reprod Biol Endocrinol       Date:  2011-05-06       Impact factor: 5.211

9.  Effect of glycemic treatment and microvascular complications on menopause in women with type 1 diabetes in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) cohort.

Authors:  Catherine Kim; Patricia A Cleary; Catherine C Cowie; Barbara H Braffett; Rodney L Dunn; Mary E Larkin; Patricia M Gatcomb; Hunter B Wessells; David M Nathan; Aruna V Sarma
Journal:  Diabetes Care       Date:  2013-10-29       Impact factor: 19.112

Review 10.  Contraception for women with diabetes: challenges and solutions.

Authors:  Ann Robinson; Chidiebere Nwolise; Jill Shawe
Journal:  Open Access J Contracept       Date:  2016-03-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.